Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Purchase of 50,000 LRMR shares, $166.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Larimar Therapeutics, Inc. (LRMR) | Purchase | 50,000 | $166.9K |
| Jun 12, 2026 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/Award | 8,641 | n/a |
| May 20, 2026 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 55,150 | n/a |
| Mar 2, 2026 | Larimar Therapeutics, Inc. (LRMR) | Purchase | 100,000 | $500.0K |
| May 15, 2025 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/Award | 8,961 | n/a |
| May 14, 2025 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 19,000 | n/a |
| May 31, 2024 | Larimar Therapeutics, Inc. (LRMR) | Purchase | 57,208 | $500.0K |
| May 17, 2024 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/Award | 8,583 | n/a |
| May 19, 2023 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/Award | 8,167 | n/a |
| May 11, 2023 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 8,300 | n/a |